spacer
home > epc > spring 2002 > maintaining validation control over edc systems during a clinical study
PUBLICATIONS
European Pharmaceutical Contractor

Maintaining Validation Control Over EDC Systems During a Clinical Study

A lot has been written about the benefits of implementing electronic data capture (EDC) in the context of clinical studies. Topics commonly covered include the regulations, guidance and standards against which EDC solutions are created and implemented, the methods for maintaining data security, and those for measuring and delivering a return on investment, not to mention the general ways in which EDC affects and improves the processes of data gathering and what the future holds.

Despite the discussion about EDC there has been limited use of the technology throughout pharmaceutical companies' development pipelines. Whilst 50 per cent of companies may claim to have used EDC, this has commonly only been in pilot phase. This level of maturity is reflected in the industry estimates that EDC is still only used in between 5 per cent and 10 per cent of studies commenced on an annual basis (1).

Companies are grappling with the practical aspects of EDC implementation in a constantly changing environment. This situation presents particularly interesting challenges for the clinical research organisation (CRO) community. CROs find themselves either trying to implement a 'standard EDC solution' or deliver flexibility to their clients. Both approaches have their limiting factors. As the market matures, perhaps the latter approach best enables CROs to take advantage of the EDC technology which proves itself to satisfy the needs of their market segment.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Simon Crowe, Senior Business Development Manager, Informatics & Technology Services at PPD Development, UK

Simon Crowe has spent the last seven years working with clients in the manufacturing and pharmaceutical sectors. He has helped to specify and supply appropriate computing technology to meet the need for improved management of information. During this period Simon was responsible for all commercial aspects of a start-up EDC vendor, 4th Wave Technologies. Most recently Simon has taken on the role of Senior Business Development Manager at PPD Development.
spacer
Simon Crowe
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

AstroNova introduces its range of grass paper labels derived from grass for high quality organic products

Dietzenbach, 29 April 2019, AstroNova GmbH, European headquarters of AstroNova Inc. (RI, USA), responsible for Sales and Customer Service in Europe, the Middle East and Africa (EMEA), is extending its Product Identification range with new approved labelling for direct foodstuff contact.
More info >>

White Papers
 
Industry Events

DIA 2019 Global Annual Meeting

23-27 June 2019, San Diego Convention Center

DIA 2019 is more than just a meeting: itís where brilliant minds come together to create solutions. Thousands of global innovators will convene to engage in discussions on todayís hottest topics in the life sciences field, propose ways to combat daily challenges, and network to create lasting connections.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement